• FLOT1–FOSL2–EphA2 Axis in Alzheimer’s Disease

  2026-09-09

  A 2026 Neuropharmacology study identifies a FLOT1–FOSL2–EphA2 regulatory axis that promotes pro-inflammatory microglial polarization through p38/MAPK signaling in APP/PS1 mice. FLOT1 silencing reduced neuroinflammatory responses and improved spatial memory, supporting this pathway as a mechanistic target for Alzheimer’s disease research while highlighting the need for validation beyond transgenic models.

• NF449 Reveals a Platelet P2X1 Antithrombotic Axis

  2026-09-08

  Hechler and colleagues used NF449 to distinguish the contributions of platelet P2X1, P2Y1, and P2Y12 receptors to platelet activation and thrombosis. The study shows that preferential P2X1 blockade can reduce collagen-dependent platelet responses and experimental thrombus formation, while higher exposure produces broader P2-receptor inhibition.

• DFO for Latent Fingerprint Detection: Practical Guide

  2026-09-08

  Learn how DFO converts amino-acid residues into a fluorescence-based signal for latent fingerprint work on paper and other porous evidence. This practical guide emphasizes solvent selection, substrate-aware controls, imaging, and troubleshooting rather than treating one formulation as universally optimal.

• Native Protein Gel Electrophoresis: K4142 Guide

  2026-09-07

  This scenario-based guide explains how native protein gel electrophoresis can complement cell viability, proliferation, and cytotoxicity studies when protein structure and activity require confirmation. It details practical use of the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0), SKU K4142, for acidic protein workflows.

• SU 5402: From RTK Mechanism to Translational Models

  2026-09-07

  SU 5402 is more than a pathway inhibitor: it is a mechanistic probe for testing how receptor tyrosine kinase signaling controls proliferation, survival, and disease-relevant phenotypes. This thought-leadership guide connects its established use in multiple myeloma research and cancer biology with disciplined, clearly bounded opportunities in human neuronal models.

• Ionomycin calcium salt for calcium signaling studies

  2026-09-05

  Ionomycin calcium salt provides a direct, controllable way to elevate intracellular Ca2+ for secretion, protein-regulation, and cell-death assays. This practical guide connects calcium perturbation workflows with DNA-repair research while separating product-supported use cases from exploratory cancer-model hypotheses.

• PDHA1 Succinylation in Cholangiocarcinoma

  2026-09-04

  The reference study identifies PDHA1 lysine 83 succinylation as a metabolic–immune switch in cholangiocarcinoma. By linking altered pyruvate dehydrogenase activity to α-ketoglutaric acid accumulation, OXGR1–MAPK signaling, reduced macrophage MHC-II presentation, and chemotherapy resistance, the work provides a mechanistic rationale for targeting tumor metabolism alongside gemcitabine and cisplatin.

• SM-102 for mRNA-LNP Delivery: Practical Workflow

  2026-09-04

  SM-102 provides a practical starting point for building lipid nanoparticles that deliver reporter, vaccine, or therapeutic mRNA. This guide connects formulation design with the localized bladder-cancer use case reported in a 2026 FASEB Journal study, while separating published findings from optimization recommendations.

• Polygodial: A Strategic TRPA1 Research Tool

  2026-09-03

  Polygodial provides a practical chemical entry point for interrogating TRPA1-dependent calcium signaling, sensory biology, and epithelial inflammatory outputs. This thought-leadership guide connects channel activation with translational assay design, validation strategy, and the limitations that matter when moving from mechanistic experiments toward airway and neurophysiology research.

• Sisomicin Workflows for Antibacterial Research

  2026-09-03

  Build reproducible Sisomicin assays around concentration-controlled susceptibility testing, resistance-aware comparator design, and carefully bounded infection-model translation. The workflow also clarifies why burn-antisepsis evidence can inform endpoint selection without proving Sisomicin efficacy in wounds.

• 7-AAD Cell Viability Assay Kit for CAR-T Studies

  2026-09-02

  Use the 7-AAD Cell Viability Assay Kit to quantify membrane-compromised target and effector cells during CD38 CAR-T experiments. Its far-red signal supports multiplex workflows with Annexin V, FITC, PE, or APC markers while helping separate biological cytotoxicity from experimental loss of cell integrity.

• Electrical Stimulation Enhances Cancer-Cell Nanoparticle Upt

  2026-09-02

  The reference study shows that alternating-current electrical stimulation increases magnetic nanoparticle endocytosis in cancer cells without requiring particle-surface functionalization. By linking enhanced macropinocytosis to F-actin remodeling and elevated intracellular Ca2+, the work provides a broadly applicable strategy for improving magnetic hyperthermia and MRI readouts.

• WST-8 Glucose Uptake: An Ion-Aware Strategy

  2026-09-01

  A thought-leadership guide to using glucose uptake measurements as a functional endpoint for ion-modulated nucleic acid delivery, with practical controls, translational context, and a rigorous framework for interpreting WST-8 data.

• Triamcinolone B1859: Practical Research Guide

  2026-09-01

  This guide provides a dossier-based workflow for preparing, storing, and quality-checking Triamcinolone B1859 in controlled glucocorticoid signaling, inflammation, and immunosuppression studies. It is intended for scientific research only and should not be used for diagnostic, clinical, or therapeutic applications.

• PP 3: A Better Control for Src Pathway Studies

  2026-08-31

  A translational perspective on PP 3 as a matched negative control for PP 2, using vascular ROS and L-type calcium-channel biology to strengthen Src kinase pathway validation.

8056 records 1/538 page Next 12345 下5页 Last page